Literature DB >> 11595682

Where to next with retinoids for cancer therapy?

M A Smith, B Anderson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11595682

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  5 in total

1.  Synergistic efficacy of a novel combination therapy controls growth of Bcl-x(L) bountiful neuroblastoma cells by increasing differentiation and apoptosis.

Authors:  Nishant Mohan; Naren L Banik; Swapan K Ray
Journal:  Cancer Biol Ther       Date:  2011-11-01       Impact factor: 4.742

2.  Retinoids induce differentiation and downregulate telomerase activity and N-Myc to increase sensitivity to flavonoids for apoptosis in human malignant neuroblastoma SH-SY5Y cells.

Authors:  Arabinda Das; Naren L Banik; Swapan K Ray
Journal:  Int J Oncol       Date:  2009-03       Impact factor: 5.650

3.  Effect of retinoic acid and delta-like 1 homologue (DLK1) on differentiation in neuroblastoma.

Authors:  Yuri Kim
Journal:  Nutr Res Pract       Date:  2010-08-31       Impact factor: 1.926

4.  Bryostatin-1, Fenretinide and 1α,25 (OH)(2)D(3) Induce Growth Inhibition, Apoptosis and Differentiation in T and B Cell-Derived Acute Lymphoblastic Leukemia Cell Lines (CCRF-CEM and Nalm-6).

Authors:  Ali M Ardekani; Shahrzad Soleymani Fard; Mahmood Jeddi-Tehrani; Ramin Ghahremanzade
Journal:  Avicenna J Med Biotechnol       Date:  2011-10

5.  A phase 1 study of tazarotene in adults with advanced cancer.

Authors:  P H Jones; R D Burnett; I Fainaru; P Nadolny; P Walker; Z Yu; D Tang-Liu; T S Ganesan; D C Talbot; A L Harris; G J S Rustin
Journal:  Br J Cancer       Date:  2003-09-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.